November 13, 2009
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
As subject population will be determined via retrospective chart review, we are not actively recruiting subjects.
Data will be collected by the co-investigators through a retrospective chart review
of all patients with elbow flexion deformities secondary to cerebral palsy, who
have undergone corrective elbow surgery performed by the primary investigator.
Specifically, outcomes of fractional lengthening and full elbow release procedures
will be investigated. Pre and post-operative elbow range of motion, angle during
ambulation will be compared.
N/A – we are not actively recruiting subjects.
Krystle Hearns MA,
Co-Director of Research, CHArm Center
hearnsk@hss.edu
212.774.7519